SlideShare a Scribd company logo
WELCOME
Dr. A.K.M. Kamruzzaman
FCPS Student, BSMMU.
Tetralogy of Fallot
Overview
Epidemiology
Pathophysiology
Hemodynamic
Clinical presentation
Blue spell
Evaluation
Complication
Management
Prognosis
History
1671 Danish
anatomist Nils
Steno
The first description
1777 Sandifort described a .“blue boy.” with the
anatomic features of TOF
1784 William Hunter cyanotic spells and poor growth in a
boy with TOF
Louis-Etienne Fallot ( A French physician) in 1888 , first correlate
the clinical and pathological features of TOF
1924 Maude Abbott coined the term“tetralogy of
Fallot.”
1936 produced the first illustrations of the pathologic and circulatory
features, and described x-ray and electrocardiographic features of TOF
 One of the conotruncal family of heart lesions
 Primary defect is an anterior deviation of the
infundibular septum
- Obstruction of RVOT(PS)
- VSD
- Overriding of aorta
- RVH
Tetralogy of fallot
 Most common congenital cyanotic heart disease
 Occurs in 3 of every 10,000 live births, and
 Accounts for 7–10% of all congenital cardiac
malformations.
Epidemiology
 Multifactorial
 But associations include
untreated maternal diabetes, phenylketonuria, &
intake of retinoic acid.
 Associated chromosomal anomalies include
trisomies 21, 18, and 13
 The risk of recurrence in families is 3%.
Etiology
Recent experience points to the much more frequent association of
microdeletions of chromosome 22. 22q11.2 deletion syndrome
Developmental Fault
• Defective embryonic neural crest migration- abnormal
conotruncal development.
• Incomplete rotation and faulty partitioning of the
conotruncus during separation.
• Malrotation of truncal-bulbar ridges results in mis-
alignment of the outlet and trabecular septum and
consequent straddling of the aorta over the malaligned
VSD.
• Abnormally anterior septation of the conotruncus by the
bulbotruncal ridges- subpulmonic obstruction.
Lesion Frequency in TOF
Structural
Pulmonary atresia
Atrial septal defect
Additional VSD
Atrioventricular septal defect
PDA
Dextrocardia
12%
20%
5%
1-3%
4-6%
2%
Vascular
Right aortic arch
Congenital absence of Pul valve
Coronary artery anomaly
Aberrant subclavian artery
MAPCAS
15-25%
3%
3-8%
2%
Additional structural and vascular lesions in TOF
Hemodynamic
Tetralogy Of Fallot
• Obstruction of RVOT(PS)
• Ventricular septal defect
• Overriding of aorta
• Right ventricular hypertrophy
Pathophysiology
Owing to right ventricular obstruction
during ventricular systole
deoxygenated blood of right ventricle
shunts through VSD to the left ventricle,
mix with oxygenated blood and this
mixed blood passes through the aorta
to different parts of the body.
• The flow occurs across the pulmonic stenosis
producing an ejection systolic murmur --
more severe the pulmonic stenosis, the less the
flow into the pulmonary artery and the bigger
the right to left shunt
• more severe the pulmonic stenosis, the shorter
the ejection systolic murmur and the more the
cyanosis
• the severity of cyanosis is directly proportional
to the severity of pulmonic stenosis, but the
intensity of the systolic murmur is inversely
related to the severity of pulmonic stenosis
• the right ventricular
outflow obstruction
results in the delay in the
P2 -- since the
pulmonary artery
pressure is reduced, the
P2 is also reduced in
intensity -- the late and
soft P2 is generally
inaudible in TOF -- the
S2 is , therefore, single and
the audible sound is A2 --
 since the aorta is
somewhat anteriorly
displaced, the audible
single A2 is quite loud.
The VSD of TOF is always large enough to allow free exit to
the right to left shunt --- since the right ventricle is
effectively decompressed by the VSD --- congestive failure
almost never occurs in TOF.
As the systolic pressures between two ventricle are
identical there is little or no shunt and the VSD is silent
The degree of RVOT obstruction determines
 The timing of the onset of symptoms
 Severity of cyanosis
 Degree of RVH
RVOT obstruction
Mild- moderate
Balanced shunt across the VSD
No visibly cyanosed-Pink TOF
Severe
Cyanosis will be present
from birth
Clinical Features
From History
• Exertional dyspnea
• Cyanosis
• Paroxysomal blue
spells
• Growth failure
• Developmental
delay
 Cyanosis , clubbing
 Conjunctival congestion
 Pulse: Normal
 Blood pressure : Normal
 Normal sized heart with parasternal impulse, a
systolic thrill in less than 30 % patients.
Physical examination
Normal first sound, Single second sound
 An ejection systolic murmur : Loud & harsh, most
intensity at the left sternal border
 Occasionally continuous murmur ( if prominent
collaterals are present)
Physical examination
Paroxysmal hypercyanotic attack
Hypoxic, blue or tet spell
 Particular problem during the 1st 2 years of life
 Hyperpneic, restless, cyanosis increases,
gasping respiration & syncope
 Frequently occur in the morning on awakening or
after episodes of vigorous crying
 Last for few min to hrs
 Onset is spontaneous & unpredictable
Paroxysmal hypercyanotic attack
 Short episodes are followed by generalized
weakness & sleep
 Severe spell progress to unconsciousness,
occasionally to convulsion/ hemiparesis
 Temporary disappearance /↓ in intensity of the
systolic murmur
Occurs due to already compromised pulmonary blood flow as a result
of severe hypoxia & metabolic acidosis
Investigation
CBC with PBF
Polycythemia
Feature of iron deficiency anemia
1. Boot shaped heart(“coeur en
sabot”) : apex is lifted up, narrow
base & there is a concavity in the
region of pulmonary artery
2. Normal heart size
3. Oligaemic lung fields
4. Hilar vessels are few, lung
vessels also few
X ray chest
ECG
Right axis deviation
RVH
Tall peaked p wave may be present
 The extent of aortic
override of the septum
 Location & degree of the
RVOT obstruction
 The size of pulmonary
valve annulus
 The side of aortic arch
Echocardiography
Cardiac catheterization
 Presence of multiple VSDs
 Degree &levels of stenosis in
right ventricular outflow
tract, pulmonary arteries,
coronary artery anomaly.
Complication
 Hypercyanotic spell
 Cerebral thrombosis
 Cerebral abscess
 Infective endocarditis
 Hyperuremia & gout : 2ndary to polycythemia
 Relative iron deficiency anemia
 Bleeding disorder
 Coagulopathy
Treatment
 General measure
 Management of hyper cyanotic spell
 Surgery
 Treatment of complication
 Prophylaxis
Treatment depends upon the RVOT
obstruction
Severe tetralogy require urgent
medical treatment & surgical
intervention in neonatal period
Less severe obstruction,
stable & waiting for surgery
1. Oxygenation
2. Prevention of hypothermia
3. I/V PG E1 (.01-.02
micro/kg/min)
4. Monitoring of blood
glucose
1. Oral propanolol (0.5-1
mg/kg every 6hr)
2. Prevention/prompt
treatment of
dehydration
3. Iron supplementation
Management of cyanotic spell
1.Knee chest position:
1) Constriction of Femoral artery PVR left
ventricular presser Rt- Lt shunt improves
pulmonary blood flow better oxygenation &
improves cyanosis
2) Constriction of femoral vein venous return
Rt- Lt shunt
• It is difficult to achieve to
knee-chest position. It is
favorable to hold the child
in parents shoulder with
knees bent and oxygen is
administered by another
person from behind.
2. Oxygen: Oxygen to improve oxygenation. It is better given
in nebulized form .
3. Morphine: Depresses respiratory center→abolishes
hyperpnea→ decreases Systemic Venous Return. 0.2mg/kg
SC.
4. IV fluids: to correct dehydration
5. Inj NaHCO3: (1-2 meq/kg intravenously slowly). To
correct metabolic acidosis
6. Propanolol: 0.1-0.2 mg/kg I/V over 5 min.
 Reduces dynamic RVOT obstruction and slow the HR
thereby decreasing R→L shunting.
 Increase SVR by antagonizing the vasodilating effects
of β2 adrenergic stimulation.
7. Phenylephrine Hydrochloride: 0.01 mg/kg IV (slowly) or
0.1 mg/kg SC or IM (Improve RV outflow, ↓R→L shunt
8. Ketamine: 0.25- 1.0 mg/kg. IV or IM→ has dual benefit
causes sedation and ↑ SVR
9. Premature attempts to obtain blood samples should be
avoided.
Long Term medical Management
1. Educate the parents to recognize the spell and know what
to do.
2. Oral propanolol therapy ,0.5-1.5 mg/kg every 6 hr
3. Maintenance of good dental hygiene and practice of
antibiotic prophylaxis against SBE are important.
Long Term medical Management (cont’)
4. A relative iron deficiency state should be
detected and treated.
5. Hct values are usually normal so RBC indices and PBF
should be monitored.
Surgical tratment
Surgical
Palliative Shunt Procedures :
-To increase pulmonary blood flow
Indications:
1. Neonates with TOF and pulmonary atresia.
2. Infants with hypoplastic pulmonary annulus.
3. Infants younger than 3-4 months with medically
unmanageable hypoxic spells.
 Classic Blalock-Taussing shunt-(SA-PA)
 Modified B-T shunt- A Gore-Tax interposition is placed
between the Subclavian Artery and the ipsilateral
Pulmonary Artery
 Potts operation- between the descending aorta and left PA.
 Waterson Shunt-a between ascending aorta and right PA.
Corrective /Complete Repair Surgery:
Indications
1. Oxygen saturation <75 to 80%.
2. Occurrence of hypoxic spell
3. Mildly cyanotic infants who have had
previous shunt surgery
4. Asymptomatic children with coronary artery
anomalies.
Timing
Symptomatic infants may have primary repair at 4-
6months.Most centers prefer primary elective repair by 1 to
2years of age .
The procedure include
- Patch closure of VSD
- Relief of RVOT obstruction by resecting
obstructive muscle bundle
- And Pulmonary valvotomy
Surgical mortality rate is <5%
Natural course/Prognosis
Depends upon
- Severity of RVOT obs
- Associated other malformation
- Management
NATURAL HISTORY
1. Infants with acyanotic TOF gradually become cyanotic.
Patients who are already cyanotic become more cyanotic
as a result of the worsening condition of the infundibular
stenosis and polycythemia.
2. Polycythemia develops secondary to cyanosis.
3. Development of relative iron-deficiency state (i.e.,
hypochromia)
NATURAL HISTORY(contd.)
4. Hypoxic spells may develop in infants
5. Growth retardation may be present if cyanosis is
severe
6. Brain abscess and cerebrovascular accident rarely
occur
7. SBE is occasionally a complication.
8. Some patients, particularly those with severe
TOF, develop AR.
9. Coagulopathy is a late complication of a long-
standing cyanosis.
• The survival for untreated Tetralogy of Fallot is
approximately 75% after the first year of life, 60%
by four years, 30% by ten years, and 5% by forty
years.
TOF with RVOT
obstruction
Clinical course Survival
Mild
Obstruction
Cyanosis appear in
childhood
3rd-4th decade
Moderate Cyanosis since early
infancy
2nd-3rd decade
Severe Cyanosed since birth Seldom survive
beyond 2nd decade
Without surgery around 50% of children with TOF will
die within the first few years of life and survival beyond
30 years is uncommon.
With corrective surgery in childhood, survival is 95-
99%, and almost all children can be expected to survive to
adulthood.
seminar on TOF

More Related Content

What's hot

Management of acute lvf
Management of acute lvfManagement of acute lvf
Management of acute lvf
Gautam Chakma
 
Coarctation of aorta
Coarctation of aortaCoarctation of aorta
Coarctation of aorta
Jerin Thunduparambil
 
Approach to cyanotic congenital heart diseases
Approach to cyanotic congenital heart diseases Approach to cyanotic congenital heart diseases
Approach to cyanotic congenital heart diseases
Nagendra prasad Kulari
 
Cyanotic heart disease
Cyanotic heart diseaseCyanotic heart disease
Cyanotic heart disease
Ramachandra Barik
 
Tricuspid atresia
Tricuspid atresiaTricuspid atresia
Tricuspid atresia
Dina Mostafa
 
Tetralogy of Fallot : Dr. Akif Baig
Tetralogy of Fallot : Dr. Akif BaigTetralogy of Fallot : Dr. Akif Baig
Tetralogy of Fallot : Dr. Akif Baig
akifab93
 
Transposition of the great arteries
Transposition of the great arteriesTransposition of the great arteries
Transposition of the great arteries
jagan _jaggi
 
Alcapa
AlcapaAlcapa
Alcapa
hospital
 
Tof physiology
Tof physiologyTof physiology
Tof physiology
Amit Verma
 
Non infarction Q waves
Non infarction Q wavesNon infarction Q waves
Non infarction Q waves
Aby Thankachan
 
Management Of PDA
Management Of PDAManagement Of PDA
Management Of PDA
Shubhra Paul
 
Atrial flutter (AFl) – management principals
Atrial flutter (AFl) – management principalsAtrial flutter (AFl) – management principals
Atrial flutter (AFl) – management principals
Prithvi Puwar
 
Patent Ductus Arteriosus on the Newborn
Patent Ductus Arteriosus on the NewbornPatent Ductus Arteriosus on the Newborn
Patent Ductus Arteriosus on the Newborn
Sid Kaithakkoden
 
INTRA AORTIC BALLON PUMP (IABP)
INTRA AORTIC BALLON PUMP (IABP)INTRA AORTIC BALLON PUMP (IABP)
INTRA AORTIC BALLON PUMP (IABP)
Malleswara rao Dangeti
 
Tricuspid atresia
Tricuspid atresiaTricuspid atresia
Tricuspid atresia
radhikauppal8
 
Patent ductus arteriosus
Patent ductus arteriosusPatent ductus arteriosus
Patent ductus arteriosus
Christian Medical College & Hospital
 
Acyanotic heart diseases
Acyanotic heart diseasesAcyanotic heart diseases
Acyanotic heart diseases
mohanasundariskrose
 
Management of cyanotic congenital heart diseae3
Management of  cyanotic congenital heart diseae3Management of  cyanotic congenital heart diseae3
Management of cyanotic congenital heart diseae3Sandip Gupta
 
Congenital cyanotic heart disease approach
Congenital cyanotic heart disease approachCongenital cyanotic heart disease approach
Congenital cyanotic heart disease approachVarsha Shah
 

What's hot (20)

Management of acute lvf
Management of acute lvfManagement of acute lvf
Management of acute lvf
 
Coarctation of aorta
Coarctation of aortaCoarctation of aorta
Coarctation of aorta
 
Coarctation Of Aorta
Coarctation Of AortaCoarctation Of Aorta
Coarctation Of Aorta
 
Approach to cyanotic congenital heart diseases
Approach to cyanotic congenital heart diseases Approach to cyanotic congenital heart diseases
Approach to cyanotic congenital heart diseases
 
Cyanotic heart disease
Cyanotic heart diseaseCyanotic heart disease
Cyanotic heart disease
 
Tricuspid atresia
Tricuspid atresiaTricuspid atresia
Tricuspid atresia
 
Tetralogy of Fallot : Dr. Akif Baig
Tetralogy of Fallot : Dr. Akif BaigTetralogy of Fallot : Dr. Akif Baig
Tetralogy of Fallot : Dr. Akif Baig
 
Transposition of the great arteries
Transposition of the great arteriesTransposition of the great arteries
Transposition of the great arteries
 
Alcapa
AlcapaAlcapa
Alcapa
 
Tof physiology
Tof physiologyTof physiology
Tof physiology
 
Non infarction Q waves
Non infarction Q wavesNon infarction Q waves
Non infarction Q waves
 
Management Of PDA
Management Of PDAManagement Of PDA
Management Of PDA
 
Atrial flutter (AFl) – management principals
Atrial flutter (AFl) – management principalsAtrial flutter (AFl) – management principals
Atrial flutter (AFl) – management principals
 
Patent Ductus Arteriosus on the Newborn
Patent Ductus Arteriosus on the NewbornPatent Ductus Arteriosus on the Newborn
Patent Ductus Arteriosus on the Newborn
 
INTRA AORTIC BALLON PUMP (IABP)
INTRA AORTIC BALLON PUMP (IABP)INTRA AORTIC BALLON PUMP (IABP)
INTRA AORTIC BALLON PUMP (IABP)
 
Tricuspid atresia
Tricuspid atresiaTricuspid atresia
Tricuspid atresia
 
Patent ductus arteriosus
Patent ductus arteriosusPatent ductus arteriosus
Patent ductus arteriosus
 
Acyanotic heart diseases
Acyanotic heart diseasesAcyanotic heart diseases
Acyanotic heart diseases
 
Management of cyanotic congenital heart diseae3
Management of  cyanotic congenital heart diseae3Management of  cyanotic congenital heart diseae3
Management of cyanotic congenital heart diseae3
 
Congenital cyanotic heart disease approach
Congenital cyanotic heart disease approachCongenital cyanotic heart disease approach
Congenital cyanotic heart disease approach
 

Similar to seminar on TOF

Cyan
CyanCyan
Cyan
sangpeds
 
Tetralogy of Fallot (TOF)
 Tetralogy of Fallot (TOF) Tetralogy of Fallot (TOF)
Tetralogy of Fallot (TOF)
Syed Kamrul Hasan
 
Classification of Congential Heart Diseases and cyanotic heart disease
Classification of Congential Heart Diseases and cyanotic heart diseaseClassification of Congential Heart Diseases and cyanotic heart disease
Classification of Congential Heart Diseases and cyanotic heart disease
Christian Medical College & Hospital
 
Congenital heart diseases
Congenital heart diseasesCongenital heart diseases
Congenital heart diseases
Abdulmalik Abdulateef
 
Congenital heart disease
Congenital heart diseaseCongenital heart disease
Congenital heart disease
Dr. Armaan Singh
 
Topic Critical Congenital Heart Disease
Topic Critical Congenital Heart DiseaseTopic Critical Congenital Heart Disease
Topic Critical Congenital Heart Disease
Bow Aya
 
Cyanotic heart disease complete ppts
Cyanotic heart disease complete pptsCyanotic heart disease complete ppts
Cyanotic heart disease complete ppts
DrMuddasarHussain
 
Cyanotic Heart Defects
Cyanotic Heart DefectsCyanotic Heart Defects
Cyanotic Heart DefectsTosca Torres
 
CONGENITAL HEART DISEASE & ANAESTHESIA by Dr.Sravani Vishnubhatla
CONGENITAL HEART DISEASE & ANAESTHESIA by Dr.Sravani VishnubhatlaCONGENITAL HEART DISEASE & ANAESTHESIA by Dr.Sravani Vishnubhatla
CONGENITAL HEART DISEASE & ANAESTHESIA by Dr.Sravani Vishnubhatla
DrSravaniVishnubhatl
 
Congenital heart diseases.pptx
Congenital heart diseases.pptxCongenital heart diseases.pptx
Congenital heart diseases.pptx
maneeshsen2
 
Patent Ductus Arteriosus
Patent Ductus ArteriosusPatent Ductus Arteriosus
Patent Ductus ArteriosusShams Patel
 
Approach to Cyanotic Congenital Heart Diseases
Approach to Cyanotic Congenital Heart DiseasesApproach to Cyanotic Congenital Heart Diseases
Approach to Cyanotic Congenital Heart DiseasesCSN Vittal
 
Congenital Cyanotic heart disease
Congenital Cyanotic heart diseaseCongenital Cyanotic heart disease
Congenital Cyanotic heart disease
Sonali Paradhi Mhatre
 
Pediatric Cardiology - for medical students
Pediatric Cardiology - for medical studentsPediatric Cardiology - for medical students
Pediatric Cardiology - for medical students
faculty of medicine
 
Congenital heart disease
Congenital heart diseaseCongenital heart disease
Congenital heart disease
Surendra Sharma
 
Congenital heart diseases
Congenital heart diseasesCongenital heart diseases
Congenital heart diseases
Tigreentertainment
 
Congenital Heart Disease.ppt
Congenital Heart Disease.pptCongenital Heart Disease.ppt
Congenital Heart Disease.ppt
DrAliAlsaady1
 
Approach to cyanotic congenital heart disease in new born
Approach to cyanotic congenital heart disease in new bornApproach to cyanotic congenital heart disease in new born
Approach to cyanotic congenital heart disease in new born
Jigar Patel
 
Cynotic congenital heart disease UG Class Dr Jyothi.pptx
Cynotic congenital heart disease UG Class Dr Jyothi.pptxCynotic congenital heart disease UG Class Dr Jyothi.pptx
Cynotic congenital heart disease UG Class Dr Jyothi.pptx
hamsinin16
 

Similar to seminar on TOF (20)

Cyan
CyanCyan
Cyan
 
Tetralogy of Fallot (TOF)
 Tetralogy of Fallot (TOF) Tetralogy of Fallot (TOF)
Tetralogy of Fallot (TOF)
 
Classification of Congential Heart Diseases and cyanotic heart disease
Classification of Congential Heart Diseases and cyanotic heart diseaseClassification of Congential Heart Diseases and cyanotic heart disease
Classification of Congential Heart Diseases and cyanotic heart disease
 
Congenital heart diseases
Congenital heart diseasesCongenital heart diseases
Congenital heart diseases
 
Congenital heart disease
Congenital heart diseaseCongenital heart disease
Congenital heart disease
 
Topic Critical Congenital Heart Disease
Topic Critical Congenital Heart DiseaseTopic Critical Congenital Heart Disease
Topic Critical Congenital Heart Disease
 
Cyanotic heart disease complete ppts
Cyanotic heart disease complete pptsCyanotic heart disease complete ppts
Cyanotic heart disease complete ppts
 
Cyanotic Heart Defects
Cyanotic Heart DefectsCyanotic Heart Defects
Cyanotic Heart Defects
 
CONGENITAL HEART DISEASE & ANAESTHESIA by Dr.Sravani Vishnubhatla
CONGENITAL HEART DISEASE & ANAESTHESIA by Dr.Sravani VishnubhatlaCONGENITAL HEART DISEASE & ANAESTHESIA by Dr.Sravani Vishnubhatla
CONGENITAL HEART DISEASE & ANAESTHESIA by Dr.Sravani Vishnubhatla
 
Congenital heart diseases.pptx
Congenital heart diseases.pptxCongenital heart diseases.pptx
Congenital heart diseases.pptx
 
Cyanotic Heart Diseases
Cyanotic Heart DiseasesCyanotic Heart Diseases
Cyanotic Heart Diseases
 
Patent Ductus Arteriosus
Patent Ductus ArteriosusPatent Ductus Arteriosus
Patent Ductus Arteriosus
 
Approach to Cyanotic Congenital Heart Diseases
Approach to Cyanotic Congenital Heart DiseasesApproach to Cyanotic Congenital Heart Diseases
Approach to Cyanotic Congenital Heart Diseases
 
Congenital Cyanotic heart disease
Congenital Cyanotic heart diseaseCongenital Cyanotic heart disease
Congenital Cyanotic heart disease
 
Pediatric Cardiology - for medical students
Pediatric Cardiology - for medical studentsPediatric Cardiology - for medical students
Pediatric Cardiology - for medical students
 
Congenital heart disease
Congenital heart diseaseCongenital heart disease
Congenital heart disease
 
Congenital heart diseases
Congenital heart diseasesCongenital heart diseases
Congenital heart diseases
 
Congenital Heart Disease.ppt
Congenital Heart Disease.pptCongenital Heart Disease.ppt
Congenital Heart Disease.ppt
 
Approach to cyanotic congenital heart disease in new born
Approach to cyanotic congenital heart disease in new bornApproach to cyanotic congenital heart disease in new born
Approach to cyanotic congenital heart disease in new born
 
Cynotic congenital heart disease UG Class Dr Jyothi.pptx
Cynotic congenital heart disease UG Class Dr Jyothi.pptxCynotic congenital heart disease UG Class Dr Jyothi.pptx
Cynotic congenital heart disease UG Class Dr Jyothi.pptx
 

More from Dr. Habibur Rahim

neuromonitoring of a newborn from common nervous system disease perspectives ...
neuromonitoring of a newborn from common nervous system disease perspectives ...neuromonitoring of a newborn from common nervous system disease perspectives ...
neuromonitoring of a newborn from common nervous system disease perspectives ...
Dr. Habibur Rahim
 
basics of mechanical ventilator Dr Asaduzzaman.pptx
basics of mechanical ventilator Dr Asaduzzaman.pptxbasics of mechanical ventilator Dr Asaduzzaman.pptx
basics of mechanical ventilator Dr Asaduzzaman.pptx
Dr. Habibur Rahim
 
approach to Rh Isoimmunization Maternal and neonatal aspects | Dr Habibur Rahim
approach to Rh Isoimmunization Maternal and neonatal aspects | Dr Habibur Rahimapproach to Rh Isoimmunization Maternal and neonatal aspects | Dr Habibur Rahim
approach to Rh Isoimmunization Maternal and neonatal aspects | Dr Habibur Rahim
Dr. Habibur Rahim
 
Short Bowel syndrome Dr Habibur Rahim
Short Bowel syndrome Dr Habibur RahimShort Bowel syndrome Dr Habibur Rahim
Short Bowel syndrome Dr Habibur Rahim
Dr. Habibur Rahim
 
Approach to Baby of perinatal asphyxia | Dr Sonia Akter | Dr Habibur Rahim
Approach to Baby of perinatal asphyxia | Dr Sonia Akter | Dr Habibur RahimApproach to Baby of perinatal asphyxia | Dr Sonia Akter | Dr Habibur Rahim
Approach to Baby of perinatal asphyxia | Dr Sonia Akter | Dr Habibur Rahim
Dr. Habibur Rahim
 
Seminar on critical Congenital heart disease Dr Habibur Rahim | Dr Faria Yasmin
Seminar on critical Congenital heart disease Dr Habibur Rahim | Dr Faria YasminSeminar on critical Congenital heart disease Dr Habibur Rahim | Dr Faria Yasmin
Seminar on critical Congenital heart disease Dr Habibur Rahim | Dr Faria Yasmin
Dr. Habibur Rahim
 
Approach to Intrauterine growth restriction
Approach to Intrauterine growth restrictionApproach to Intrauterine growth restriction
Approach to Intrauterine growth restriction
Dr. Habibur Rahim
 
Seminar on pulmonary hemorrhage in newborn by Dr. Habib, Dr. Ashfaq
Seminar on pulmonary hemorrhage in newborn by Dr. Habib, Dr. AshfaqSeminar on pulmonary hemorrhage in newborn by Dr. Habib, Dr. Ashfaq
Seminar on pulmonary hemorrhage in newborn by Dr. Habib, Dr. Ashfaq
Dr. Habibur Rahim
 
seminar on RDS by dr. Shahana
seminar on RDS by dr. Shahanaseminar on RDS by dr. Shahana
seminar on RDS by dr. Shahana
Dr. Habibur Rahim
 
seminar on Acute kidney injury in newborn
seminar on Acute kidney injury in newborn seminar on Acute kidney injury in newborn
seminar on Acute kidney injury in newborn
Dr. Habibur Rahim
 
Seminar on DSD
Seminar on DSDSeminar on DSD
Seminar on DSD
Dr. Habibur Rahim
 
CPAP seminar final
CPAP seminar finalCPAP seminar final
CPAP seminar final
Dr. Habibur Rahim
 
Seminar on neonatal cholestasis
Seminar on neonatal cholestasisSeminar on neonatal cholestasis
Seminar on neonatal cholestasis
Dr. Habibur Rahim
 
seminar Presentation covid 19 in children
seminar Presentation covid 19 in childrenseminar Presentation covid 19 in children
seminar Presentation covid 19 in children
Dr. Habibur Rahim
 
Seminar on shock
Seminar on shockSeminar on shock
Seminar on shock
Dr. Habibur Rahim
 
seminar on Management of shock
seminar on Management of shockseminar on Management of shock
seminar on Management of shock
Dr. Habibur Rahim
 
seminar on MAS
seminar on MASseminar on MAS
seminar on MAS
Dr. Habibur Rahim
 
seminar ASD
seminar ASDseminar ASD
seminar ASD
Dr. Habibur Rahim
 
seminar Meningitis
seminar Meningitisseminar Meningitis
seminar Meningitis
Dr. Habibur Rahim
 
seminar on urinary tract infection
seminar on urinary tract infectionseminar on urinary tract infection
seminar on urinary tract infection
Dr. Habibur Rahim
 

More from Dr. Habibur Rahim (20)

neuromonitoring of a newborn from common nervous system disease perspectives ...
neuromonitoring of a newborn from common nervous system disease perspectives ...neuromonitoring of a newborn from common nervous system disease perspectives ...
neuromonitoring of a newborn from common nervous system disease perspectives ...
 
basics of mechanical ventilator Dr Asaduzzaman.pptx
basics of mechanical ventilator Dr Asaduzzaman.pptxbasics of mechanical ventilator Dr Asaduzzaman.pptx
basics of mechanical ventilator Dr Asaduzzaman.pptx
 
approach to Rh Isoimmunization Maternal and neonatal aspects | Dr Habibur Rahim
approach to Rh Isoimmunization Maternal and neonatal aspects | Dr Habibur Rahimapproach to Rh Isoimmunization Maternal and neonatal aspects | Dr Habibur Rahim
approach to Rh Isoimmunization Maternal and neonatal aspects | Dr Habibur Rahim
 
Short Bowel syndrome Dr Habibur Rahim
Short Bowel syndrome Dr Habibur RahimShort Bowel syndrome Dr Habibur Rahim
Short Bowel syndrome Dr Habibur Rahim
 
Approach to Baby of perinatal asphyxia | Dr Sonia Akter | Dr Habibur Rahim
Approach to Baby of perinatal asphyxia | Dr Sonia Akter | Dr Habibur RahimApproach to Baby of perinatal asphyxia | Dr Sonia Akter | Dr Habibur Rahim
Approach to Baby of perinatal asphyxia | Dr Sonia Akter | Dr Habibur Rahim
 
Seminar on critical Congenital heart disease Dr Habibur Rahim | Dr Faria Yasmin
Seminar on critical Congenital heart disease Dr Habibur Rahim | Dr Faria YasminSeminar on critical Congenital heart disease Dr Habibur Rahim | Dr Faria Yasmin
Seminar on critical Congenital heart disease Dr Habibur Rahim | Dr Faria Yasmin
 
Approach to Intrauterine growth restriction
Approach to Intrauterine growth restrictionApproach to Intrauterine growth restriction
Approach to Intrauterine growth restriction
 
Seminar on pulmonary hemorrhage in newborn by Dr. Habib, Dr. Ashfaq
Seminar on pulmonary hemorrhage in newborn by Dr. Habib, Dr. AshfaqSeminar on pulmonary hemorrhage in newborn by Dr. Habib, Dr. Ashfaq
Seminar on pulmonary hemorrhage in newborn by Dr. Habib, Dr. Ashfaq
 
seminar on RDS by dr. Shahana
seminar on RDS by dr. Shahanaseminar on RDS by dr. Shahana
seminar on RDS by dr. Shahana
 
seminar on Acute kidney injury in newborn
seminar on Acute kidney injury in newborn seminar on Acute kidney injury in newborn
seminar on Acute kidney injury in newborn
 
Seminar on DSD
Seminar on DSDSeminar on DSD
Seminar on DSD
 
CPAP seminar final
CPAP seminar finalCPAP seminar final
CPAP seminar final
 
Seminar on neonatal cholestasis
Seminar on neonatal cholestasisSeminar on neonatal cholestasis
Seminar on neonatal cholestasis
 
seminar Presentation covid 19 in children
seminar Presentation covid 19 in childrenseminar Presentation covid 19 in children
seminar Presentation covid 19 in children
 
Seminar on shock
Seminar on shockSeminar on shock
Seminar on shock
 
seminar on Management of shock
seminar on Management of shockseminar on Management of shock
seminar on Management of shock
 
seminar on MAS
seminar on MASseminar on MAS
seminar on MAS
 
seminar ASD
seminar ASDseminar ASD
seminar ASD
 
seminar Meningitis
seminar Meningitisseminar Meningitis
seminar Meningitis
 
seminar on urinary tract infection
seminar on urinary tract infectionseminar on urinary tract infection
seminar on urinary tract infection
 

Recently uploaded

basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 

Recently uploaded (20)

basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 

seminar on TOF

  • 4. History 1671 Danish anatomist Nils Steno The first description 1777 Sandifort described a .“blue boy.” with the anatomic features of TOF 1784 William Hunter cyanotic spells and poor growth in a boy with TOF Louis-Etienne Fallot ( A French physician) in 1888 , first correlate the clinical and pathological features of TOF 1924 Maude Abbott coined the term“tetralogy of Fallot.” 1936 produced the first illustrations of the pathologic and circulatory features, and described x-ray and electrocardiographic features of TOF
  • 5.  One of the conotruncal family of heart lesions  Primary defect is an anterior deviation of the infundibular septum - Obstruction of RVOT(PS) - VSD - Overriding of aorta - RVH Tetralogy of fallot
  • 6.
  • 7.  Most common congenital cyanotic heart disease  Occurs in 3 of every 10,000 live births, and  Accounts for 7–10% of all congenital cardiac malformations. Epidemiology
  • 8.  Multifactorial  But associations include untreated maternal diabetes, phenylketonuria, & intake of retinoic acid.  Associated chromosomal anomalies include trisomies 21, 18, and 13  The risk of recurrence in families is 3%. Etiology Recent experience points to the much more frequent association of microdeletions of chromosome 22. 22q11.2 deletion syndrome
  • 9. Developmental Fault • Defective embryonic neural crest migration- abnormal conotruncal development. • Incomplete rotation and faulty partitioning of the conotruncus during separation. • Malrotation of truncal-bulbar ridges results in mis- alignment of the outlet and trabecular septum and consequent straddling of the aorta over the malaligned VSD. • Abnormally anterior septation of the conotruncus by the bulbotruncal ridges- subpulmonic obstruction.
  • 10. Lesion Frequency in TOF Structural Pulmonary atresia Atrial septal defect Additional VSD Atrioventricular septal defect PDA Dextrocardia 12% 20% 5% 1-3% 4-6% 2% Vascular Right aortic arch Congenital absence of Pul valve Coronary artery anomaly Aberrant subclavian artery MAPCAS 15-25% 3% 3-8% 2% Additional structural and vascular lesions in TOF
  • 12. Tetralogy Of Fallot • Obstruction of RVOT(PS) • Ventricular septal defect • Overriding of aorta • Right ventricular hypertrophy
  • 13. Pathophysiology Owing to right ventricular obstruction during ventricular systole deoxygenated blood of right ventricle shunts through VSD to the left ventricle, mix with oxygenated blood and this mixed blood passes through the aorta to different parts of the body.
  • 14. • The flow occurs across the pulmonic stenosis producing an ejection systolic murmur -- more severe the pulmonic stenosis, the less the flow into the pulmonary artery and the bigger the right to left shunt • more severe the pulmonic stenosis, the shorter the ejection systolic murmur and the more the cyanosis • the severity of cyanosis is directly proportional to the severity of pulmonic stenosis, but the intensity of the systolic murmur is inversely related to the severity of pulmonic stenosis
  • 15. • the right ventricular outflow obstruction results in the delay in the P2 -- since the pulmonary artery pressure is reduced, the P2 is also reduced in intensity -- the late and soft P2 is generally inaudible in TOF -- the S2 is , therefore, single and the audible sound is A2 --  since the aorta is somewhat anteriorly displaced, the audible single A2 is quite loud.
  • 16. The VSD of TOF is always large enough to allow free exit to the right to left shunt --- since the right ventricle is effectively decompressed by the VSD --- congestive failure almost never occurs in TOF. As the systolic pressures between two ventricle are identical there is little or no shunt and the VSD is silent
  • 17. The degree of RVOT obstruction determines  The timing of the onset of symptoms  Severity of cyanosis  Degree of RVH RVOT obstruction Mild- moderate Balanced shunt across the VSD No visibly cyanosed-Pink TOF Severe Cyanosis will be present from birth
  • 18. Clinical Features From History • Exertional dyspnea • Cyanosis • Paroxysomal blue spells • Growth failure • Developmental delay
  • 19.  Cyanosis , clubbing  Conjunctival congestion  Pulse: Normal  Blood pressure : Normal  Normal sized heart with parasternal impulse, a systolic thrill in less than 30 % patients. Physical examination
  • 20. Normal first sound, Single second sound  An ejection systolic murmur : Loud & harsh, most intensity at the left sternal border  Occasionally continuous murmur ( if prominent collaterals are present) Physical examination
  • 21. Paroxysmal hypercyanotic attack Hypoxic, blue or tet spell  Particular problem during the 1st 2 years of life  Hyperpneic, restless, cyanosis increases, gasping respiration & syncope  Frequently occur in the morning on awakening or after episodes of vigorous crying  Last for few min to hrs  Onset is spontaneous & unpredictable
  • 22.
  • 23. Paroxysmal hypercyanotic attack  Short episodes are followed by generalized weakness & sleep  Severe spell progress to unconsciousness, occasionally to convulsion/ hemiparesis  Temporary disappearance /↓ in intensity of the systolic murmur Occurs due to already compromised pulmonary blood flow as a result of severe hypoxia & metabolic acidosis
  • 25. 1. Boot shaped heart(“coeur en sabot”) : apex is lifted up, narrow base & there is a concavity in the region of pulmonary artery 2. Normal heart size 3. Oligaemic lung fields 4. Hilar vessels are few, lung vessels also few X ray chest
  • 26. ECG Right axis deviation RVH Tall peaked p wave may be present
  • 27.  The extent of aortic override of the septum  Location & degree of the RVOT obstruction  The size of pulmonary valve annulus  The side of aortic arch Echocardiography
  • 28. Cardiac catheterization  Presence of multiple VSDs  Degree &levels of stenosis in right ventricular outflow tract, pulmonary arteries, coronary artery anomaly.
  • 29. Complication  Hypercyanotic spell  Cerebral thrombosis  Cerebral abscess  Infective endocarditis  Hyperuremia & gout : 2ndary to polycythemia  Relative iron deficiency anemia  Bleeding disorder  Coagulopathy
  • 30. Treatment  General measure  Management of hyper cyanotic spell  Surgery  Treatment of complication  Prophylaxis
  • 31. Treatment depends upon the RVOT obstruction Severe tetralogy require urgent medical treatment & surgical intervention in neonatal period Less severe obstruction, stable & waiting for surgery 1. Oxygenation 2. Prevention of hypothermia 3. I/V PG E1 (.01-.02 micro/kg/min) 4. Monitoring of blood glucose 1. Oral propanolol (0.5-1 mg/kg every 6hr) 2. Prevention/prompt treatment of dehydration 3. Iron supplementation
  • 32. Management of cyanotic spell 1.Knee chest position: 1) Constriction of Femoral artery PVR left ventricular presser Rt- Lt shunt improves pulmonary blood flow better oxygenation & improves cyanosis 2) Constriction of femoral vein venous return Rt- Lt shunt
  • 33. • It is difficult to achieve to knee-chest position. It is favorable to hold the child in parents shoulder with knees bent and oxygen is administered by another person from behind.
  • 34. 2. Oxygen: Oxygen to improve oxygenation. It is better given in nebulized form . 3. Morphine: Depresses respiratory center→abolishes hyperpnea→ decreases Systemic Venous Return. 0.2mg/kg SC. 4. IV fluids: to correct dehydration 5. Inj NaHCO3: (1-2 meq/kg intravenously slowly). To correct metabolic acidosis
  • 35. 6. Propanolol: 0.1-0.2 mg/kg I/V over 5 min.  Reduces dynamic RVOT obstruction and slow the HR thereby decreasing R→L shunting.  Increase SVR by antagonizing the vasodilating effects of β2 adrenergic stimulation.
  • 36. 7. Phenylephrine Hydrochloride: 0.01 mg/kg IV (slowly) or 0.1 mg/kg SC or IM (Improve RV outflow, ↓R→L shunt 8. Ketamine: 0.25- 1.0 mg/kg. IV or IM→ has dual benefit causes sedation and ↑ SVR 9. Premature attempts to obtain blood samples should be avoided.
  • 37. Long Term medical Management 1. Educate the parents to recognize the spell and know what to do. 2. Oral propanolol therapy ,0.5-1.5 mg/kg every 6 hr 3. Maintenance of good dental hygiene and practice of antibiotic prophylaxis against SBE are important.
  • 38. Long Term medical Management (cont’) 4. A relative iron deficiency state should be detected and treated. 5. Hct values are usually normal so RBC indices and PBF should be monitored.
  • 40. Surgical Palliative Shunt Procedures : -To increase pulmonary blood flow Indications: 1. Neonates with TOF and pulmonary atresia. 2. Infants with hypoplastic pulmonary annulus. 3. Infants younger than 3-4 months with medically unmanageable hypoxic spells.
  • 41.  Classic Blalock-Taussing shunt-(SA-PA)  Modified B-T shunt- A Gore-Tax interposition is placed between the Subclavian Artery and the ipsilateral Pulmonary Artery  Potts operation- between the descending aorta and left PA.  Waterson Shunt-a between ascending aorta and right PA.
  • 42.
  • 43. Corrective /Complete Repair Surgery: Indications 1. Oxygen saturation <75 to 80%. 2. Occurrence of hypoxic spell 3. Mildly cyanotic infants who have had previous shunt surgery 4. Asymptomatic children with coronary artery anomalies.
  • 44. Timing Symptomatic infants may have primary repair at 4- 6months.Most centers prefer primary elective repair by 1 to 2years of age . The procedure include - Patch closure of VSD - Relief of RVOT obstruction by resecting obstructive muscle bundle - And Pulmonary valvotomy Surgical mortality rate is <5%
  • 45. Natural course/Prognosis Depends upon - Severity of RVOT obs - Associated other malformation - Management
  • 46. NATURAL HISTORY 1. Infants with acyanotic TOF gradually become cyanotic. Patients who are already cyanotic become more cyanotic as a result of the worsening condition of the infundibular stenosis and polycythemia. 2. Polycythemia develops secondary to cyanosis. 3. Development of relative iron-deficiency state (i.e., hypochromia)
  • 47. NATURAL HISTORY(contd.) 4. Hypoxic spells may develop in infants 5. Growth retardation may be present if cyanosis is severe 6. Brain abscess and cerebrovascular accident rarely occur 7. SBE is occasionally a complication. 8. Some patients, particularly those with severe TOF, develop AR. 9. Coagulopathy is a late complication of a long- standing cyanosis.
  • 48. • The survival for untreated Tetralogy of Fallot is approximately 75% after the first year of life, 60% by four years, 30% by ten years, and 5% by forty years.
  • 49. TOF with RVOT obstruction Clinical course Survival Mild Obstruction Cyanosis appear in childhood 3rd-4th decade Moderate Cyanosis since early infancy 2nd-3rd decade Severe Cyanosed since birth Seldom survive beyond 2nd decade
  • 50. Without surgery around 50% of children with TOF will die within the first few years of life and survival beyond 30 years is uncommon. With corrective surgery in childhood, survival is 95- 99%, and almost all children can be expected to survive to adulthood.